It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The human endogenous retrovirus K (HERV-K) is the most recently acquired endogenous retrovirus in the human genome and is activated and expressed in many cancers and amyotrophic lateral sclerosis. We present the immature HERV-K capsid structure at 3.2 Å resolution determined from native virus-like particles using cryo-electron tomography and subtomogram averaging. The structure shows a hexamer unit oligomerized through a 6-helix bundle, which is stabilized by a small molecule analogous to IP6 in immature HIV-1 capsid. The HERV-K immature lattice is assembled via highly conserved dimer and trimer interfaces, as detailed through all-atom molecular dynamics simulations and supported by mutational studies. A large conformational change mediated by the linker between the N-terminal and the C-terminal domains of CA occurs during HERV-K maturation. Comparison between HERV-K and other retroviral immature capsid structures reveals a highly conserved mechanism for the assembly and maturation of retroviruses across genera and evolutionary time.
The hexagonal immature capsid lattice of human endogenous retrovirus K is determined at 3.2 Å resolution, which is an assembly of small molecule-stabilized hexamers via dimer and trimer interfaces, a highly conserved mechanism among retroviruses.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Wellcome Trust Centre for Human Genetics, University of Oxford, Division of Structural Biology, Oxford, UK (GRID:grid.270683.8) (ISNI:0000 0004 0641 4511)
2 Duke University School of Medicine, Department of Biochemistry, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961)
3 Duke University, Department of Computer Science, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961)
4 University of Delaware, Department of Chemistry and Biochemistry, Newark, USA (GRID:grid.33489.35) (ISNI:0000 0001 0454 4791)
5 Diamond Light Source, Harwell Science and Innovation Campus, Didcot, UK (GRID:grid.18785.33) (ISNI:0000 0004 1764 0696)
6 Duke University School of Medicine, Department of Biochemistry, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University, Department of Computer Science, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University, Department of Electrical and Computer Engineering, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961)
7 Wellcome Trust Centre for Human Genetics, University of Oxford, Division of Structural Biology, Oxford, UK (GRID:grid.270683.8) (ISNI:0000 0004 0641 4511); Diamond Light Source, Harwell Science and Innovation Campus, Didcot, UK (GRID:grid.18785.33) (ISNI:0000 0004 1764 0696); Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)